Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-interventional, Non-treatment, Non-randomized, Single Coordinating Center, Decentralized Bio-specimen Collection Study in USA-based Adult Subjects With Acquired Resistance to KRAS Inhibitors

NCT05272423 is registered in ClinicalTrials.gov with Addario Lung Cancer Medical Institute as lead sponsor.

NCT NCT05272423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05272423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-interventional, Non-treatment, Non-randomized, Single Coordinating Center, Decentralized Bio-specimen Collection Study in USA-based Adult Subjects With Acquired Resistance to KRAS Inhibitors
Lead sponsor
Addario Lung Cancer Medical Institute
Phase
Observational
Overall status
Completed
Start date
September 8, 2022
Completion date
April 6, 2026
Enrollment
58 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kras p.g12c